Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fresenius Medical Care AG (FMS) Gross Margin (2016 - 2025)

Historic Gross Margin for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to 25.43%.

  • Fresenius Medical Care AG's Gross Margin rose 13500.0% to 25.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 25.02%, marking a year-over-year decrease of 1100.0%. This contributed to the annual value of 24.6% for FY2024, which is 7100.0% down from last year.
  • Latest data reveals that Fresenius Medical Care AG reported Gross Margin of 25.43% as of Q3 2025, which was up 13500.0% from 25.35% recorded in Q2 2025.
  • Fresenius Medical Care AG's 5-year Gross Margin high stood at 29.72% for Q2 2021, and its period low was 6.95% during Q4 2022.
  • Its 5-year average for Gross Margin is 24.14%, with a median of 25.0% in 2024.
  • Over the last 5 years, Fresenius Medical Care AG's Gross Margin had its largest YoY gain of 201200bps in 2023, and its largest YoY loss of -34900bps in 2023.
  • Quarter analysis of 5 years shows Fresenius Medical Care AG's Gross Margin stood at 7.49% in 2021, then decreased by -7bps to 6.95% in 2022, then soared by 289bps to 27.06% in 2023, then decreased by -8bps to 25.0% in 2024, then increased by 2bps to 25.43% in 2025.
  • Its Gross Margin was 25.43% in Q3 2025, compared to 25.35% in Q2 2025 and 24.26% in Q1 2025.